-
Metformin may improve immunotherapy efficacy in obese lung cancer patients: Study
19 Dec 2024 20:09 GMT
… in the Journal of the National Cancer Institute found that metformin which … this expanding demographic and improve lung cancer-specific clinical outcomes in individuals … In JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP). https …
-
FDA Approves Ensartinib for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
19 Dec 2024 19:10 GMT
… -or-metastatic-non-small-cell-lung-cancer
2. eXalt3: Study Comparing X … /study/NCT02767804
3. National Cancer Institute. NCI Drug Dictionary — ensartinib. Accessed December …
-
How to Protect Yourself as Cancer Rates Rise Among People Under 50
20 Dec 2024 22:06 GMT
Historically, cancer has been associated with aging. The median age of a cancer diagnosis is 66, and the risk of cancer increases with age. Yet, data from the American Cancer Society (ACS) reveals an alarming trend: The incidence of cancer among people …
-
GSK’s FIRST-ENGOT-OV44 phase III clinical trial of Zejula and Jemperl in first line advanced ovarian cancer meets primary endpoint
21 Dec 2024 03:37 GMT
… National du Cancer or French NCI) developing and conducting gynaecological and … therapies for gynaecologic, colorectal and lung cancers, as well as where there …
-
These common supplements could be raising your cancer risk
20 Dec 2024 18:21 GMT
Many people consider dietary supplements as the quick fix to improve their health and do not hesitate to take high doses without consultation from a health expert. Many turn to these pills in hopes of preventing cancer, however, indiscriminate use of …
-
Plus Therapeutics presents ReSPECT─LM phase 1 trial data for breast cancer patients with leptomeningeal metastases
20 Dec 2024 13:12 GMT
Plus Therapeutics, Inc, a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, presented data updating the progress of its ReSPECT-LM phase 1 clinical trial of …
-
One Year in Cancer Research and Much to Celebrate
20 Dec 2024 19:25 GMT
December 20, 2024,
by Kimryn Rathmell, M.D., Ph.D.
Dr. W. Kimryn Rathmell, M.D., Ph.D.
NCI Director
As 2024 comes to a close, I’ve been reflecting on what’s transpired in cancer and cancer research over the past year. Yesterday, in fact, marked my one-year …
-
The Dangerous Intersection of Breast Cancer and Cardiovascular Disease: A Call for Improved Prevention
20 Dec 2024 00:36 GMT
Every 14 seconds, somewhere in the world, a woman is diagnosed with breast cancer.1 It is the most common cancer worldwide, with over 2.3 million diagnosed per year.1 There are approximately 4.1 million female breast cancer survivors in the United States, …
-
GSK announces FIRST trial met its primary endpoint of progression free survival in first line advanced ovarian cancer
20 Dec 2024 07:13 GMT
… National du Cancer or French NCI) developing and conducting gynecological and … therapies for gynaecologic, colorectal and lung cancers, as well as where there …
-
Expert warns of the common supplements that could give you cancer
19 Dec 2024 02:16 GMT
A dietitian has revealed the common supplements that could increase the risk of cancers forming.
Nichole Andrews, an oncology dietitian in Washington State, warned that while common supplements like vitamins C have been touted for boosting the immune …
About
© 1995-2024